GSA Capital Partners’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $346K | Buy |
+36,708
| New | +$403K | 0.02% | 1162 |
|
|
2024
Q4 | – | Sell |
-52,850
| Closed | -$960K | – | 1784 |
|
|
2024
Q3 | $960K | Buy |
+52,850
| New | +$1.23M | 0.07% | 492 |
|
|
2023
Q3 | – | Sell |
-9,799
| Closed | -$403K | – | 1676 |
|
|
2023
Q2 | $403K | Buy |
+9,799
| New | +$472K | 0.04% | 875 |
|
|
2022
Q3 | – | Sell |
-11,151
| Closed | -$602K | – | 1681 |
|
|
2022
Q2 | $602K | Buy |
+11,151
| New | +$670K | 0.09% | 381 |
|
|
2021
Q3 | – | Sell |
-22,148
| Closed | -$1.51M | – | 1586 |
|
|
2021
Q2 | $1.51M | Buy |
+22,148
| New | +$1.57M | 0.17% | 117 |
|
|
2021
Q1 | – | Sell |
-6,368
| Closed | -$413K | – | 1268 |
|
|
2020
Q4 | $413K | Buy |
6,368
+317
| +5% | +$17.1K | 0.07% | 544 |
|
|
2020
Q3 | $286K | Buy |
+6,051
| New | +$288K | 0.05% | 769 |
|
|
2020
Q1 | – | Sell |
-5,079
| Closed | -$296K | – | 1275 |
|
|
2019
Q4 | $296K | Sell |
5,079
-13,305
| -72% | -$792K | 0.03% | 1037 |
|
|
2019
Q3 | $1.1M | Buy |
18,384
+2,984
| +19% | +$178K | 0.15% | 125 |
|
|
2019
Q2 | $860K | Buy |
15,400
+1,108
| +8% | +$57.1K | 0.1% | 310 |
|
|
2019
Q1 | $796K | Buy |
+14,292
| New | +$728K | 0.08% | 411 |
|
|
2018
Q3 | – | Sell |
-8,355
| Closed | -$538K | – | 1748 |
|
|
2018
Q2 | $538K | Buy |
+8,355
| New | +$517K | 0.03% | 1120 |
|
|
2017
Q4 | – | Sell |
-28,249
| Closed | -$1.43M | – | 1668 |
|
|
2017
Q3 | $1.43M | Buy |
28,249
+19,226
| +213% | +$987K | 0.1% | 305 |
|
|
2017
Q2 | $492K | Sell |
9,023
-42,283
| -82% | -$2.02M | 0.03% | 1013 |
|
|
2017
Q1 | $2.16M | Buy |
51,306
+46,090
| +884% | +$1.97M | 0.12% | 226 |
|
|
2016
Q4 | $224K | Sell |
5,216
-148
| -3% | -$6.02K | 0.01% | 1523 |
|
|
2016
Q3 | $221K | Sell |
5,364
-15,718
| -75% | -$658K | 0.01% | 1548 |
|
|
2016
Q2 | $841K | Buy |
21,082
+4,278
| +25% | +$154K | 0.05% | 743 |
|
|
2016
Q1 | $566K | Sell |
16,804
-51,440
| -75% | -$1.6M | 0.04% | 929 |
|
|
2015
Q4 | $2.31M | Buy |
68,244
+42,040
| +160% | +$1.31M | 0.11% | 205 |
|
|
2015
Q3 | $780K | Buy |
26,204
+6,383
| +32% | +$200K | 0.04% | 840 |
|
|
2015
Q2 | $546K | Sell |
19,821
-3,181
| -14% | -$84.8K | 0.02% | 1301 |
|
|
2015
Q1 | $580K | Buy |
23,002
+11,499
| +100% | +$272K | 0.02% | 1278 |
|
|
2014
Q4 | $255K | Buy |
+11,503
| New | +$233K | 0.02% | 1355 |
|
|
2014
Q1 | – | Sell |
-15,662
| Closed | -$305K | – | 1662 |
|
|
2013
Q4 | $305K | Sell |
15,662
-734
| -4% | -$13.5K | 0.02% | 1187 |
|
|
2013
Q3 | $270K | Buy |
+16,396
| New | +$263K | 0.02% | 1215 |
|
Other funds holding IART
RCMNY
PCMI
VPM
VCM
GSA Capital Partners's IART Position: Q1 2026 in Review
GSA Capital Partners opened a new position in Integra LifeSciences (IART) in Q1 2026: 36,708 shares worth $346K. The stake represents 0.02% of the portfolio and ranks #1162 among its holdings. This is a return to the name: GSA Capital Partners previously reported a position in IART as recently as Q3 2024.
GSA Capital Partners first reported a position in IART in Q3 2013 and has held it in 26 quarters since. The position peaked at $2.31M in Q4 2015. 201 funds tracked by Wall St. Rank hold IART as of Q1 2026.
- GSA Capital Partners held 36,708 shares of Integra LifeSciences worth $346K as of Q1 2026.
- Integra LifeSciences was a new GSA Capital Partners position in Q1 2026.
- Integra LifeSciences made up 0.02% of GSA Capital Partners's portfolio in Q1 2026, its #1162 holding.
- GSA Capital Partners first reported a position in Integra LifeSciences in Q3 2013 and has held it in 26 quarters since.
- GSA Capital Partners's Integra LifeSciences position peaked at $2.31M in Q4 2015.
- 201 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2026.
Based on GSA Capital Partners's 13F filing for Q1 2026, filed 8 May 2026.